Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
FULC
#4057
Fulcrum Therapeutics, Inc. Common Stock
8.3
8
-3.68%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-3.68%
Monatliche Änderung
-23.26%
6 month change
+25.26%
Jahresänderung
+145.75%
Vorheriger Schlusskurs
8.7
0
Open
8.3
8
Bid
Ask
Low
8.3
8
High
8.3
8
Volumen
82
Märkte
Aktien
Gesundheitswesen
FULC
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
32.67 M
40.64 M
61.76 M
61.94 M
53.98 M
66.6 M
—
Valuation ratios
Enterprise value
325.54 M
683.46 M
452.8 M
420.99 M
195.49 M
555.72 M
1.45 B
Price to earnings ratio
—
—
-3.24
-4.53
-29.38
-9.58
-4.91
Price to sales ratio
—
—
0.06
0.16
0
—
—
Price to cash flow ratio
—
—
0
0
0.13
0.01
-0.06
Price to book ratio
—
—
0
0
0
0
0.01
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.55
0.34
0.48
0.38
0.04
0.2
0.3
Return on equity %
0.74
0.38
0.55
0.41
0.04
0.21
0.31
Return on invested capital %
694.39
255.15
242.06
217.3
41.52
188.47
—
Gross margin %
100
100
100
100
100
—
—
Operating margin %
811.64
422.97
1 774.85
3 945.24
27.37
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
802.66
421.89
1 732.43
3 470.05
12.16
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.47
11.77
12.41
17.71
22.63
27.4
98.22
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.07
0.11
0.03
0.01
0.31
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
2 157.1
1 483.69
35.78
948.07
270.23
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
780.11
416.95
939.15
3 117.88
3 133.39
Net current asset value per share
—
—
4 612.46
3 950.4
4 032.06
5 642.49
5 719.88
Tangible book value per share
—
—
4 421.82
3 836.13
3 920.92
5 508.64
15.76 K
Working capital per share
—
—
4 240.71
3 727.35
3 853.88
5 436.54
5 510.55
Book value per share
—
—
4 421.82
3 836.13
3 920.92
5 508.64
5 584.08
Nachrichten
Fulcrum: Strong HbF Signal, Narrow TAM, Same 'Hold' Conclusion (NASDAQ:FULC)
Fulcrum Therapeutics stock falls as sickle cell trial misses target
Leerink bestätigt "Outperform"-Rating für Fulcrum Therapeutics nach Daten zur Sichelzellkrankheit/n
Leerink reiterates Fulcrum Therapeutics stock rating on SCD data
Fulcrum Therapeutics: BofA bestätigt Underperform-Rating und Kursziel von 7 $
BofA reiterates Fulcrum Therapeutics stock Underperform rating at $7
Stifel bestätigt Kaufempfehlung für Fulcrum Therapeutics nach positiven Studiendaten
Stifel reiterates Fulcrum Therapeutics stock rating on drug data
Gewinnmitnahmen belasten Fulcrum-Aktie – Oppenheimer bestätigt positives Rating
Fulcrum Therapeutics shares fall on profit-taking, Oppenheimer says
Fulcrum Therapeutics: Aktie bricht trotz positiver Studiendaten ein
Fulcrum Therapeutics stock tumbles despite trial results